First Horizon Advisors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

First Horizon Advisors’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,220	Closed	-$71K	–	1506
2017 Q4	$71K	Sell	1,220 -61	-5%	-$3.34K	0.01%	456
2017 Q3	$74K	Sell	1,281 -14	-1%	-$820	0.01%	424
2017 Q2	$76K	Sell	1,295 -85	-6%	-$4.84K	0.01%	418
2017 Q1	$80K	Buy	+1,380	New	+$68K	0.01%	437

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

First Horizon Advisors's BIVV Position: Q1 2018 in Review

First Horizon Advisors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 1,220 shares — an estimated $71K sold.

First Horizon Advisors first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $80K in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

First Horizon Advisors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
First Horizon Advisors sold 1,220 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $71K.
First Horizon Advisors first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
First Horizon Advisors's Bioverativ Inc. Common Stock position peaked at $80K in Q1 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on First Horizon Advisors's 13F filing for Q1 2018, filed 2 May 2018.